Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10035770 Compounds, compositions and methods

Patent 10035770 was granted and assigned to Cytokinetics on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Pu-Ping Lu0

Bradley Paul Morgan0

David J. Morgans, Jr.0

Erica Anne Kraynack0

Todd Tochimoto0

Alex Muci0

Date of Patent

July 31, 2018

0

Patent Application Number

154806180

Date Filed

April 6, 2017

0

Patent Citations Received

US Patent 11986474 Methods for treating heart failure by administering cardiac sarcomere activators

0

US Patent 11472773 Salt of omecamtiv mecarbil and process for preparing salt

0

US Patent 11299479 Bisamide sarcomere activating compounds and uses thereof

US Patent 11753394 Synthesis of omecamtiv mecarbil

US Patent 11780826 Bisamide sarcomere activating compounds and uses thereof

US Patent 11384053 Heterocyclic compounds and their uses

US Patent 11884630 Heterocyclic compounds and their uses

0

US Patent 11926592 Salts and crystal forms of omecamtiv mecarbil

0

...

Patent Primary Examiner

Alexander R Pagano

0

Patent abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10035770 Compounds, compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.